McGaw Posts $3.8-Million 2nd-Quarter Profit

McGaw Inc., the Irvine provider of intravenous therapy products and services, posted a second-quarter profit of $3.8 million, or 14 cents a share.

The profit included an extraordinary gain of $800,000 from a onetime tax benefit for a loss recorded in the first quarter. For the second quarter of 1992, the company reported a loss of $6 million, or 30 cents a share.

Revenue for the April-to-June quarter was up 12%, to $82 million from $73.3 million. A net loss of $3.4 million, or 14 cents a share, for the first half compared to a year-earlier loss of $9.5 million, or 49 cents a share. First-half revenue of $161.3 million was up 12%, from $144 million.